BeiGene Grants Share Options, RSUs under Incentive Plan

MT Newswires Live

Sep 05, 2024

BeiGene (HKG:6160, SHA:688235) granted options to three grantees to subscribe for an aggregate of 3,754 American Depositary Shares (ADSs) on Aug. 30, a Thursday bourse filing said.

The options, which were granted under a 2016 share option and incentive plan, are exercisable at $198.37 per ADS for a period of 10 years.

The company, on the same day, granted a total of 66,829 restricted share unit (RSUs) to 179 Grantees under the same scheme. The RSUs represent 868,777 underlying shares, representing around 0.06% of the company's total issued share capital.

Following the grant of the options and RSUs, the drug company will have 81,050,878 underlying shares available for future grants under the award plan.

Hong Kong-listed shares of the company closed nearly 3% higher on Thursday.

Price (HKD): $115.10, Change: $+2.9, Percent Change: +2.58%

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2465491065"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2465491065\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2465491065?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-05 17:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2465491065","market":"fut","top_or_hot":-1,"title":"BeiGene Grants Share Options, RSUs under Incentive Plan","media":"MT Newswires Live","content":"<html><body><p> BeiGene (HKG:6160, SHA:688235) granted options to three grantees to subscribe for an aggregate of 3,754 American Depositary Shares (ADSs) on Aug. 30, a Thursday bourse filing said.</p><p>The options, which were granted under a 2016 share option and incentive plan, are exercisable at $198.37 per ADS for a period of 10 years.</p><p>The company, on the same day, granted a total of 66,829 restricted share unit (RSUs) to 179 Grantees under the same scheme. The RSUs represent 868,777 underlying shares, representing around 0.06% of the company's total issued share capital.</p><p>Following the grant of the options and RSUs, the drug company will have 81,050,878 underlying shares available for future grants under the award plan.</p><p>Hong Kong-listed shares of the company closed nearly 3% higher on Thursday.</p><p>Price (HKD): $115.10, Change: $+2.9, Percent Change: +2.58%</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BeiGene Grants Share Options, RSUs under Incentive Plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeiGene Grants Share Options, RSUs under Incentive Plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-09-05 17:42</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> BeiGene (HKG:6160, SHA:688235) granted options to three grantees to subscribe for an aggregate of 3,754 American Depositary Shares (ADSs) on Aug. 30, a Thursday bourse filing said.</p><p>The options, which were granted under a 2016 share option and incentive plan, are exercisable at $198.37 per ADS for a period of 10 years.</p><p>The company, on the same day, granted a total of 66,829 restricted share unit (RSUs) to 179 Grantees under the same scheme. The RSUs represent 868,777 underlying shares, representing around 0.06% of the company's total issued share capital.</p><p>Following the grant of the options and RSUs, the drug company will have 81,050,878 underlying shares available for future grants under the award plan.</p><p>Hong Kong-listed shares of the company closed nearly 3% higher on Thursday.</p><p>Price (HKD): $115.10, Change: $+2.9, Percent Change: +2.58%</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4526","symbol_name":"热门中概股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2465491065","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2465491065","pubTimestamp":1725529353,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"BeiGene  granted options to three grantees to subscribe for an aggregate of 3,754 American Depositary Shares  on Aug. 30, a Thursday bourse filing said.The options, which were granted under a 2016 share option and incentive plan, are exercisable at $198.37 per ADS for a period of 10 years.The company, on the same day, granted a total of 66,829 restricted share unit  to 179 Grantees under the same scheme. The RSUs represent 868,777 underlying shares, representing around 0.06% of the company's total issued share capital.Following the grant of the options and RSUs, the drug company will have 81,050,878 underlying shares available for future grants under the award plan.Hong Kong-listed shares of the company closed nearly 3% higher on Thursday.Price : $115.10, Change: $+2.9, Percent Change: +2.58%","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"688235":"百济神州","BK4526":"热门中概股","BK4585":"ETF&股票定投概念","BK4139":"生物科技","BK1583":"高瓴概念","BK0239":"医药制造","BK4505":"高瓴资本持仓","BK4535":"淡马锡持仓","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","HKD":"尚乘数科","BK4504":"桥水持仓","BK4588":"碎股","LU0307460666.USD":"EASTSPRING INVESTMENTS CHINA EQUITY \"A\" ACC","BK1500":"做空集合股","BK4548":"巴美列捷福持仓","LU0588546209.SGD":"Eastspring Investments - China Equity Fund AS SGD","BK1588":"回港中概股","BK1161":"生物科技","BK4023":"应用软件","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD","06160":"百济神州"},"translate_title":"百济神州根据激励计划授出购股权、受限制股份单位","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"688235":0.9,"06160":1,"BGNE":1,"HKD":1},"content_text":"BeiGene (HKG:6160, SHA:688235) granted options to three grantees to subscribe for an aggregate of 3,754 American Depositary Shares (ADSs) on Aug. 30, a Thursday bourse filing said.The options, which were granted under a 2016 share option and incentive plan, are exercisable at $198.37 per ADS for a period of 10 years.The company, on the same day, granted a total of 66,829 restricted share unit (RSUs) to 179 Grantees under the same scheme. The RSUs represent 868,777 underlying shares, representing around 0.06% of the company's total issued share capital.Following the grant of the options and RSUs, the drug company will have 81,050,878 underlying shares available for future grants under the award plan.Hong Kong-listed shares of the company closed nearly 3% higher on Thursday.Price (HKD): $115.10, Change: $+2.9, Percent Change: +2.58%","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}